Full Name: Human hepatic carcinoma HepG2 cells - Cytosolic lysate

Product Type Specific: Cytosolic lysate

Product Description: Cytosolic lysate from HepG2 cells that were cultivated to 80% confluency and deprived of serum for 18-20 hours prior to harvesting

Product Method: HepG2 cells were cultivated to 80% confluency and deprived of serum for 18-20 hours prior to harvesting. Lysates were prepared from scrapped cells that were homogenized by sonication in buffer formulated with 60 mM ß-glycerophosphate, pH 7.2, 20 mM MOPS, 20 mM sodium pyrophosphate, 30 mM sodium fluoride, 5 mM EDTA, 3 mM benzamidine, 2 mM EGTA, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonylfluoride, 1 mM dithiothreitol, 10 µM leupeptin, and 5 µM pepstatin A. Cytosolic lysates were prepared following sonication and 30 min ultracentrifugation at 100,000 rpm. Lysates were further diluted in homogenizing buffer at a final concentration of 3 mg/ml.

Storage Conditions: -70°C

Lysate Use Description: For testing antibodies by immunoprecipitation or immunoblotting, and for assays of enzymes.

Related Product 1: Cat. No.: LC0401S - HepG2 cytosolic lysate from untreated cells (3 mg/ml)

Related Product 2: Cat. No.: LC0406F - HepG2 cytosolic lysate from insulin-treated cells (3 mg/ml)

Related Product 3: Cat. No.: LC0406S - HepG2 cytosolic lysate from insulin-treated cells (2 mg/ml) in SDS-PAGE sample buffer